Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...
Hosted on MSN1mon
Nevro Stock May Gain on the CE Mark Certification for HFX iQNevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS ... indication-specific HFX Algorithm for back and leg pain, non-surgical refractory ...
GlobalData on MSN5d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Jan. 22, 2015 /PRNewswire/ -- Nevro Corp. (NYSE ... of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system. According to the approvable letter, approval ...
However, concerns regarding softness in the spinal cord stimulation (SCS ... a common source of lower back pain, Nevro seeks to address a significant gap in traditional pain management therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback